Overview

PET/MRI in the Diagnosis of Pediatric Chronic Pain

Status:
Enrolling by invitation
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
[18F]FTC-146 is a sigma-1 receptor detector and is an experimental radiotracer. Several studies have implicated involvement of sigma-1 receptors in generation and perpetuation of chronic pain conditions, while others are investigating anti sigma-1 receptor drugs for treatment of chronic pain. Using [18F]-FTC-146 and PET/MRI, we hope to learn what is the best approach to identify the source of pain generation and characterize the disease in pediatric patients with chronic pain.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Collaborator:
GE Healthcare